Results 141 to 150 of about 9,215 (199)

Precision theranostics in oncology: integrating antibody-drug conjugates, radioimmunotherapy, and immuno‑PET for adaptive cancer care. [PDF]

Discov Oncol
Wang J, Zhang Q, Cao Y, Wang C, Hamzeh S.   +4 more
europepmc   +1 more source

Treatment patterns in relapsed/refractory marginal zone lymphoma: real-world evidence from seven countries. [PDF]

Future Oncol
Patel H, Huynh L, Squires P, Prescott J, Ryland K, Catillon M, Guo T, Tamakloe K, Liu S, Duh MS, Raut M, Portell CA.   +11 more
europepmc   +1 more source

Lutetium-177 radiopharmaceuticals in cancer care: progress and challenges. [PDF]

Front Pharmacol
Shi W, Zhang L, Feng X, Liu J, Li X, Dong X, Li-Ann Wong A, Chen X, Wang L, Goh BC.   +9 more
europepmc   +1 more source

Radiotherapy-Associated Systemic Antitumor Responses Beyond the Classical Abscopal Paradigm. [PDF]

Cancers (Basel)
Dotsu Y, Akagi K, Honda N, Matsuo M, Taniguchi H, Takemoto S, Mukae H.   +6 more
europepmc   +1 more source

Increased risk of secondary malignancies after autologous transplantation in R/R follicular lymphoma: Long-term results from FIL-FLAZ12 Phase III trial. [PDF]

Hemasphere
Tavarozzi R, Evangelista A, Zanni M, Consoli C, Tucci A, Botto B, Bolis S, Lauzzana P, Zilioli VR, Puccini B, Arcari A, Pavone V, Margiotta-Casaluci G, Tani M, Cavallo F, Pinto A, Ghiggi C, Pastore D, Corradini P, Ferreri AJM, Palmas A, Patti C, Re F, Benedetti F, Milone G, Luminari S, Pennese E, Bossi E, Boccomini C, Anastasia A, Bottelli C, Mannina D, Pozzi S, Califano C, Arcaini L, Falcinelli F, Pietrantuono G, Giudice ID, Usai S, Olivieri J, Gherlinzoni F, Olivieri A, Perrone T, Pomponi F, Ciccone G, Vitolo U, Ladetto M.   +46 more
europepmc   +1 more source

Author Correction: Longitudinal single-cell and TCR repertoire profiling characterizes clonal entrapment in patients with pMMR/MSS locally advanced rectal cancer. [PDF]

Cell Discov
Tang Z, Zhu M, Zhao S, Pang D, Cui Y, Lin G, Wu A, Lin Y, Jiang X, Zhang W, Xiong N, Yang C, Wang C, Wang S, Ye Y, Bai F, Shen Z.   +16 more
europepmc   +1 more source

¹³¹I-labeled engineered hybrid cell membrane biomimetic nanocarrier targets gastric cancer and enhances radioimmunotherapy. [PDF]

Mater Today Bio
Zhang C, Chen H, Yuan Z, Dong A, Liu S, Hu L, Yang K, Zhou J.   +7 more
europepmc   +1 more source

Oncolytic adenovirus in combination with PD-L1-targeted radioimmunotherapy exerts synergistic antitumor effect against pancreatic cancer. [PDF]

J Immunother Cancer
Yoon AR, Kim S, Yi J, Zaheer J, Kim H, Seo JH, Hong J, Lee J, Jeong H, Shanmugiah J, Kim JH, Kim IW, Kim JS, Yun CO.   +13 more
europepmc   +1 more source

Radiotherapy as a partner for immunotherapy in pancreatic cancer: current landscape and future directions. [PDF]

Front Oncol
Diao Z, Wang Y, Mu S, Wu X, Yu S, Wang Z.   +5 more
europepmc   +1 more source

Radioimmunotherapy for Malignant Mesothelioma Targeting C-ERC/Mesothelin. [PDF]

Pharmaceuticals (Basel)
Hanaoka H, Yamaguchi A, Maeda M, Segawa T, Oriuchi N.   +4 more
europepmc   +1 more source